1V-LSD Blotters 150mcg research material from Raw Lab Chems
1V LSD Blotters - 150mcg Price range: € 38,00 through € 490,00
Back to products
1V-LSD Micro Pellets 10mcg research material from Raw Lab Chems
1V-LSD Micro Pellets - 10mcg Price range: € 10,00 through € 100,00

Buy 1V-LSD Pellets – 225mcg

Price range: € 62,50 through € 695,00

1V-LSD Pellets 225mcg are described as compressed research preparations associated with 1-valeroyl-lysergic acid diethylamide, an N1-acylated derivative of LSD.

The named compound, also referred to in some research contexts as Valerie, belongs to the lysergamide family and contains a valeroyl substituent at the indole nitrogen.

The supplied source identifies individual solid pellets with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.

Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related lysergamide derivatives.

The source reports CAS number 3028950-70-8 and refers to HPLC, NMR, or mass-spectrometric verification, batch identification, and Certificate of Analysis documentation.

However, no actual batch-specific analytical report or supporting certificate was supplied.

The reported molecular formula and molecular weight require reconciliation with the named compound and its actual chemical form.

Ingredient purity, finished-unit analyte content, content uniformity, excipient composition, salt form, and storage stability remain unverified.

The pellets are not established as certified reference materials or validated quantitative calibration standards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12880 Category:
Description

1V-LSD Pellets 225mcg – Valeroyl Lysergamide Research Material

1V-LSD Pellets 225mcg – Product Overview

1V-LSD Pellets 225mcg is the supplied catalog designation for a pellet-format research preparation associated with 1-valeroyl-LSD.

The named compound belongs to the lysergamide family and is structurally related to lysergic acid diethylamide.

Its molecular structure differs from LSD through the presence of a valeroyl substituent at the indole nitrogen.

The supplied source presents the product as individual compressed pellets intended for analytical and non-clinical laboratory research.

Each finished pellet is described as having a labeled analyte quantity.

However, no actual finished-unit assay or content-uniformity report accompanied the information.

The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.

The supplied scientific context includes chemical identification, chromatographic characterization, structural comparison, and stability-focused investigation.

These research contexts should be distinguished from verified findings about the actual finished pellets.

No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.

The source also refers to HPLC, NMR, or mass-spectrometric verification, batch identification, and Certificate of Analysis documentation.

These statements remain unverified without supporting records.

The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies 1V-LSD as 1-valeroyl-lysergic acid diethylamide.

It is an N1-acylated lysergamide structurally related to LSD.

The valeroyl substituent distinguishes the named compound from LSD and other N1-acylated derivatives.

The supplied chemical information includes:

  • Common designation: 1V-LSD
  • Alternative name: Valerie
  • Descriptive chemical name: 1-Valeroyl-lysergic acid diethylamide
  • Reported CAS Registry Number: 3028950-70-8
  • Chemical classification: N1-acylated lysergamide
  • Reported presentation: Compressed solid pellets
  • Labeled analyte amount: Specified per finished pellet
  • Intended designation: Research Use Only

The source reports molecular formula C23H29N3O and a molecular weight of approximately 365–367 g/mol.

These values require verification against the actual molecular structure and chemical form.

The formula C23H29N3O corresponds to a calculated molecular weight of approximately 363.50 g/mol, rather than the stated range.

The supplied source also mentions a possible hemi-L-tartrate salt.

The molecular composition and formula weight of a salt must be distinguished from those of the neutral parent compound.

No batch-specific salt-form determination, complete stereochemical characterization, or supporting chemical identity report was supplied.

The molecular structure of the named compound does not establish the composition of the finished pellet preparation.

Additional formulation components may be present, but the source does not identify them.

Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.

Chemical & Physical Characteristics

The supplied source describes the product as solid compressed pellets with a reported off-white to light-beige appearance.

No actual product-specific physical inspection report, image verification, or batch appearance record was supplied.

A pellet is a finished preparation in which the named analyte may be combined with additional formulation components.

The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.

The source does not identify the excipient composition, pellet dimensions, total unit mass, manufacturing method, or surface characteristics.

The named compound contains a valeroyl substituent attached to the lysergamide framework.

This structural feature distinguishes 1V-LSD from LSD and from related derivatives containing different N1-acyl groups.

The source also claims solubility in ethanol, DMSO, and acetone.

However, no experimentally verified solubility measurements or product-specific solvent compatibility records were supplied.

These statements should not be treated as validated extraction or analytical recovery characteristics of the finished pellets.

The source does not establish the distribution of analyte throughout the compressed formulation.

Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.

Purity & Analytical Verification

The supplied source refers to a typical ingredient purity of approximately 98–99% where verified.

However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.

The reported purity range therefore remains a supplier-provided claim rather than an independently verified result.

The source refers to HPLC, NMR spectroscopy, and mass spectrometry as analytical verification methods.

No chromatogram, NMR spectrum, mass spectrum, impurity profile, or independent laboratory certificate was supplied.

Accordingly, no specific purity result can be confirmed for the actual product batch.

For 1V-LSD Pellets 225mcg, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.

An ingredient-purity result does not independently establish finished-unit content or content uniformity.

The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.

The material is described in reference-oriented research terms.

However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.

The finished pellets should therefore not be represented as certified quantitative reference standards.

Any definitive analytical claims require actual supporting batch records.

Quality Control & Batch Integrity

The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.

These statements describe proposed or claimed quality-assurance practices.

No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.

They therefore remain unverified supplier claims.

For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.

For 1V-LSD Pellets 225mcg, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.

The supplied information does not establish independently verified analyte content, excipient composition, or content uniformity.

The source also does not provide evidence that every finished pellet meets a particular quantitative specification.

The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.

Claims concerning batch consistency and validated analytical performance should be supported by actual records.

Safety, Handling & Laboratory Precautions

1V-LSD is a synthetic lysergamide associated with significant pharmacological activity and potential toxicological uncertainty.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.  1V-LSD Pellets 225mcg

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The pellet presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual chemical form, ingredient purity, excipient composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes discreet packaging, batch-aware handling, tracking, and protective shipment arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was provided.

The source recommends storage in a sealed, moisture-resistant container in a cool, dry environment protected from light.  1V-LSD Pellets 225mcg

It also suggests refrigeration at approximately 2–8°C.

No validated product-specific stability study was supplied to establish that temperature range as a verified requirement or to support a particular shelf life.

For 1V-LSD Pellets 225mcg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 1V-LSD within analytical research involving lysergamide chemical identity, N1-acyl substitution, and comparative structural characterization.

The valeroyl substituent provides a distinguishing structural feature relevant to chemical analysis.

The source also describes interest in chromatographic profiling, analytical method development, and stability-focused laboratory research.

However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual pellets.

The Raw Lab Chems catalog identifies 1V-LSD Pellets as the product listing discussed here.

For related product-format context, the supplied catalog also includes 1V-LSD Micro Pellets and 1B-LSD Blotters.

The first related listing refers to the same named compound in a different labeled pellet format.

The second refers to 1B-LSD, a different N1-acylated lysergamide.

1V-LSD and 1B-LSD should not be treated as chemically identical or analytically interchangeable.

The supplied information does not establish equivalent chemical purity, analyte content, excipient composition, substrate composition, or content uniformity across these preparations.

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.  1V-LSD Pellets 225mcg

It also identifies possible labeled pack sizes.

No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, pack-size, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.

1V-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

1V-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.  1V-LSD Pellets 225mcg

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (pellets)

5

,

10

,

25

,

50

,

100

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy 1V-LSD Pellets – 225mcg”
Shipping & Delivery